47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.19.Z - Retail trade
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
52.10.B - Warehousing and storage of other goods
64.99.Z - Other financial services, except insurance and pension funds, not elsewhere classified
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 2,3 | 3,8 | 3,6 | -5,3 |
EBITDA | 2,3 | 3,3 | 2,9 | -12,5 |
Short time liabilities | 15,8 | 15,7 | 17,2 | 9,9 |
Equity capital | 6 | 9 | 11,9 | 31,4 |
Operating profit (EBIT) | 2,1 | 3,1 | 2,7 | -13 |
Assets | 22,4 | 25,7 | 30,1 | 17,4 |
Net profit (loss) | 1,8 | 3 | 2,8 | -5,4 |
Cash | 0,2 | 0,4 | 0,5 | 18,3 |
Net income from sale | 77,5 | 87,5 | 95,8 | 9,4 |
Liabilities and provisions for liabilities | 16,4 | 16,6 | 18,3 | 9,8 |
Working assets | 21,2 | 24,5 | 28,9 | 17,8 |
Depreciation | 0,2 | 0,2 | 0,2 | -4,8 |
% | % | % | p.p. | |
Profitability of capital | 29,9 | 33,2 | 23,9 | -9,3 |
Equity capital to total assets | 26,9 | 35,2 | 39,4 | 4,2 |
Gross profit margin | 3 | 4,3 | 3,7 | -0,6 |
EBITDA Margin | 3 | 3,7 | 3 | -0,7 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 74 | 65 | 66 | 1 |
Current financial liquidity indicator | 1.3355222940444946 | 1.5425280332565308 | 1.6422007083892822 | 0,1 |
Net dept to EBITDA | -0.10390914231538773 | -0.1008717268705368 | -0.14577020704746246 | 0 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane